Compare Hims and Hers Health Inc (HIMS) vs Range Resources Corporation Common Stock (RRC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hims and Hers Health Inc vs Range Resources Corporation Common Stock — how do they compare? Hims and Hers Health Inc trades at $26.88 (market cap $6.47B), while Range Resources Corporation Common Stock trades at $41.83 (market cap $9.93B). The key difference: Range Resources Corporation Common Stock is the larger of the two by market cap, and Range Resources Corporation Common Stock pays a 0.94% dividend while Hims and Hers Health Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Hims and Hers Health Inc for 21 Days and Range Resources Corporation Common Stock for 0 Days on average.
| HIMS | RRC | |
|---|---|---|
Market Cap | $6.47B | $9.93B |
Volume | 10,989,212 | 2,413,752 |
Sector | Health | Energy |
52-Week High | $62.76 | $47.65 |
52-Week Low | $14.52 | $33.43 |
Typical Hold Time | 21 Days | 0 Days |
Enterprise Value | $7.17B | $10.94B |
Dividend Yield | — | 0.94% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Hims & Hers Health (HIMS) trades at $29.71, down 3.04% on the day, amid a securities class action lawsuit. Technical indicators show a bullish trend, with support near $29 and resistance at $32. Fundamentally, the company reported $2.35B in 2025 revenue but swung to a net loss of -$142M in 2026, with a negative net margin of -5.51%. Valuation ratios are elevated, with a P/E of 57.14 and EV/EBITDA of 205.86. Analyst consensus is a 'Hold' with a $32.17 price target, while recent news is dominated by legal actions.
The outlook for HIMS is clouded by legal overhangs and profitability challenges despite top-line growth. Investment opportunity hinges on resolving litigation and returning to profitability, but risks include regulatory scrutiny and execution missteps. The stock's high valuation multiples require strong future earnings to justify, making it speculative in the near term.
Range Resources (RRC) trades at $42.48, up 2.56% today, with strong earnings momentum after beating estimates for three consecutive quarters. The stock shows solid fundamentals with a P/E of 11.73 and net income margin of 26.32%, while technical indicators signal neutral momentum near key resistance at $43. Recent institutional buying and positive analyst coverage (38.71% buy ratings) support the bullish case.
Outlook remains positive with Q3 2026 earnings expected at $0.776 per share and consensus price target of $44.00 offering 3.6% upside. Risks include energy price volatility and negative net cash flow of -$304M in 2025, though improved 2026 projections show operating cash flow growth to $1.4B.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Hims and Hers Health Inc
Hims & Hers is a multi-specialty telehealth platform that provides personalized health and wellness products. It offers access to medical providers and treatments for hair loss, sexual health, and skincare.
Read more on HIMS →About Range Resources Corporation Common Stock
Range Resources Corporation is an independent natural gas and natural gas liquids producer operating in the Appalachian Basin, primarily the Marcellus Shale in Pennsylvania, handling drilling, completion, and gathering and transportation connections for its production.
Read more on RRC →
